Leigh Baldwin & CO. LLC purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, HoldingsChannel reports. The fund purchased 5,407 shares of the company’s stock, valued at approximately $695,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Gables Capital Management Inc. bought a new stake in Merck KGaA during the second quarter worth approximately $2,095,000. Diversify Advisory Services LLC bought a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $3,810,000. Danske Bank A S bought a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new position in shares of Merck KGaA in the 2nd quarter worth approximately $25,541,000. Finally, BOK Financial Private Wealth Inc. purchased a new stake in Merck KGaA during the 2nd quarter valued at $523,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of MKGAF opened at $163.21 on Monday. The company has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96. The business has a fifty day moving average of $162.62 and a 200 day moving average of $148.44. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
